In line final filters for removing particles from amphotericin B infusions.
The feasibility of using membrane filters to remove particles from intravenous infusions of amphotericin B in dextrose 5% (a colloidal solution) was studied. Six types of commercial membrane filters, ranging in pore size from 0.45-1.0 mum, were used. Because of the effect of pH on the particle size of colloidal solutions, each filter was tested at solution pH 4.7, 5.6 and 6.5. Samples of filtrate were analyzed spectrophotometrically for amphotericin content. All filters of pore size 0.22 mum removed amphotericin B from solution and were inappropriate for use with this product. Solutions at pH 4.7 were turbid, filtered slowly and were generally unacceptable for clinical use. At pH 5.6, only filters with pore sizes of 1.0 mum or greater showed acceptable results. At pH 6.5, filters with pore sizes of 0.45 mum or greater gave acceptable results; the use of a filter with a pore size of not less than 1.0 mum would provide a margin for error to compensate for variations in the colloidal particle size of amphotericin B.
D000666:Amphotericin B / Q000008:administration & dosage / Q000302:isolation & purification*; D003102:Colloids; D004340:Drug Contamination / Q000517:prevention & control; D005374:Filtration; D006863:Hydrogen-Ion Concentration; D007275:Injections, Intravenous; D008566:Membranes; D010316:Particle Size
D003102:Colloids; D000666:Amphotericin B